COMMISSION ON NARCOTIC DRUGS THEMATIC SESSIONS ON THE IMPLEMENTATION OF ALL INTERNATIONAL DRUG POLICY COMMITMENTS, FOLLOWING-UP TO THE 2019 MINISTERIAL DECLARATION, 19-21 OCTOBER 2020

Agenda

Multiyear Workplan 2019-2013: Implementation of all our international drug policy commitments, following up to the 2019 ministerial declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of our Joint Commitments to Address and Counter the World Drug Problem” 

The 3rd intersessional meeting of the 63rd session of the Commission will take place from 19-21 October 2020 and will include thematic sessions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration.

Thematic session 1: Drug treatment and health services continue to fall short of meeting needs and deaths related to drug use have increased; and the rate of transmission of HIV, the hepatitis C virus and other blood-borne diseases associated with drug use, including injecting drug use in some countries, remains high; (19 October 2020) 

Thematic session 2: The adverse health consequences of and risks associated with new psychoactive substances have reached alarming levels; (20 October 2020)

Thematic session 3: The availability of internationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care, remains low to non-existent in many parts of the world; (21 October 2020) 

BACKGROUND NOTE

Background note

presentations and statements

Presentations and statements have been posted on the dedicated website.

Video messages

Ambassador Wolfgang Amadeus Bruelhart,
CND 2nd Vice-Chair

Jo Dedeyne-Amann,
CND Secretary

Giovanna Campello, UNODC Prevention, Treatment and Rehabilitation Section

Fariba Soltani,
UNODC HIV/AIDS Section

Justice Tettey, UNODC Laboratory and Scientific Section

Elizabeth Mattfeld, UNODC Prevention, Treatment and Rehabilitation Section